EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$6.33
+4.89%
Mkt Cap $261.81M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+200.2%
Consensus $19.00 vs current $6.33